Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xinle Cui & Clifford M. Snapper. (2019) Development of novel vaccines against human cytomegalovirus. Human Vaccines & Immunotherapeutics 15:11, pages 2673-2683.
Read now
Read now
Articles from other publishers (41)
Camille N. Kotton, Julian Torre‐Cisneros & Ibrahim Yakoub‐Agha. (2023) Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management. A report from the CMV International Symposium 2023. Transplant Infectious Disease.
Crossref
Crossref
Dawei Wang, Yao-Hsuan Chen & Mario Ventresca. (2023) Optimizing age specific strategies of vaccination for prevention of cytomegalovirus infection in the US using agent-based simulation. Epidemics 44, pages 100698.
Crossref
Crossref
Joanna Schaenman & Robin Avery. (2023) Cowpox to COVID: History of vaccination in the immunocompromised host. Transplant Infectious Disease 25:3.
Crossref
Crossref
Hannah Greye, Thomas Wex, Elina Taneva, Anke Redlich, Serban-Dan Costa & Anke Rissmann. (2023) Cytomegalovirus seronegativity rate in pregnant women and primary cytomegalovirus infection during pregnancy in rural Germany. BMC Pregnancy and Childbirth 23:1.
Crossref
Crossref
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, Dongyun Yang, Qiao Zhou, Ketevan Gendzekhadze, Teodora Kaltcheva, Wasima Rida, Shannon Dempsey, Shukaib Arslan, Andrew Artz, Brian Ball, Liana Nikolaenko, Vinod A. Pullarkat, Ryotaro Nakamura & Don J. Diamond. (2023) Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis. American Journal of Hematology 98:4, pages 588-597.
Crossref
Crossref
Mark R. Schleiss. 2023. Plotkin's Vaccines. Plotkin's Vaccines
258
274.e9
.
Kimberley Bruce, Jiawei Ma, Clara Lawler, Wanxiaojie Xie, Philip G. Stevenson & Helen E. Farrell. (2022) Recent Advancements in Understanding Primary Cytomegalovirus Infection in a Mouse Model. Viruses 14:9, pages 1934.
Crossref
Crossref
Steffi Krauter, Nicole Büscher, Eric Bräuchle, Samira Ortega Iannazzo, Inessa Penner, Nadine Krämer, Patricia Gogesch, Simone Thomas, Marina Kreutz, Mario Dejung, Anja Freiwald, Falk Butter, Zoe Waibler & Bodo Plachter. (2022) An Attenuated Strain of Human Cytomegalovirus for the Establishment of a Subviral Particle Vaccine. Vaccines 10:8, pages 1326.
Crossref
Crossref
Ria Goswami, Carolina Garrido Pavon, Itzayana G. Miller, Stella J. Berendam, Caitlin A. Williams, Danielle Rosenthal, Mackensie Gross, Caroline Phan, Alliyah Byrd, Justin Pollara, Sallie R. Permar & Genevieve G. Fouda. (2022) Prenatal Immunization to Prevent Viral Disease Outcomes During Pregnancy and Early Life. Frontiers in Virology 2.
Crossref
Crossref
Michael Schwendinger, Georges Thiry, Beatrice De Vos, Geert Leroux-Roels, Jacques Bruhwyler, Ariane Huygens, Corinne Ganeff, Heidemarie Buchinger, Klaus K Orlinger, Daniel D Pinschewer, Thomas P Monath & Anders E Lilja. (2022) A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus. The Journal of Infectious Diseases 225:8, pages 1399-1410.
Crossref
Crossref
Nina Singh, Drew J Winston, Raymund R Razonable, G Marshall Lyon, Fernanda P Silveira, Marilyn M Wagener & Ajit P Limaye. (2022) Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy. The Journal of Infectious Diseases 225:3, pages 436-442.
Crossref
Crossref
Mingyuan Li, Yuan Li, Shiqin Li, Lin Jia, Haomeng Wang, Meng Li, Jie Deng, Ali Zhu, Liqiao Ma, Weihong Li, Peng Yu & Tao Zhu. (2022) The nano delivery systems and applications of mRNA. European Journal of Medicinal Chemistry 227, pages 113910.
Crossref
Crossref
Xinle Cui & Clifford M. Snapper. (2021) Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Frontiers in Immunology 12.
Crossref
Crossref
Haixia Zheng, Bart N. Ford, Rayus Kuplicki, Kaiping Burrows, Peter W. Hunt, Jerzy Bodurka, T. Kent Teague, Michael R. Irwin, Robert H. Yolken, Martin P. Paulus & Jonathan Savitz. (2021) Association between cytomegalovirus infection, reduced gray matter volume, and resting-state functional hypoconnectivity in major depressive disorder: a replication and extension. Translational Psychiatry 11:1.
Crossref
Crossref
Morgan Hakki, Samuel L. Aitken, Lara Danziger-Isakov, Marian G. Michaels, Paul A. Carpenter, Roy F. Chemaly, Genovefa A. Papanicolaou, Michael Boeckh & Francisco M. Marty. (2021) American Society for Transplantation and Cellular Therapy Series: #3—Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy 27:9, pages 707-719.
Crossref
Crossref
Niyati Jakharia, Dianna Howard & David J. Riedel. (2021) CMV Infection in Hematopoietic Stem Cell Transplantation: Prevention and Treatment Strategies. Current Treatment Options in Infectious Diseases 13:3, pages 123-140.
Crossref
Crossref
Haixia Zheng, Bart N. Ford, Maurizio Bergamino, Rayus Kuplicki, Robin Aupperle, Jerzy Bodurka, Yoon-Hee Cha, Justin Feinstein, Sahib S. Khalsa, Martin P. Paulus, Jonathan Savitz, Teresa A. Victor, Peter W. Hunt, Jerzy Bodurka, T. Kent Teague, Michael R. Irwin, Robert H. Yolken, Martin P. Paulus & Jonathan Savitz. (2020) A hidden menace? Cytomegalovirus infection is associated with reduced cortical gray matter volume in major depressive disorder. Molecular Psychiatry 26:8, pages 4234-4244.
Crossref
Crossref
Sara Scarpini, Francesca Morigi, Ludovica Betti, Arianna Dondi, Carlotta Biagi & Marcello Lanari. (2021) Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice. Vaccines 9:6, pages 551.
Crossref
Crossref
Xinle Cui, Zhouhong Cao, Yuriko Ishikawa, Sara Cui, Ken-Ichi Imadome & Clifford M. Snapper. (2021) Immunization with Epstein–Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge. Vaccines 9:3, pages 285.
Crossref
Crossref
Jose F. Camargo. 2021. Emerging Transplant Infections. Emerging Transplant Infections
573
616
.
Ajit P. Limaye, Tara M. Babu & Michael Boeckh. (2020) Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation. Clinical Microbiology Reviews 34:1.
Crossref
Crossref
Virginia Sandonís, Estéfani García-Ríos, Michael J. McConnell & Pilar Pérez-Romero. (2020) Role of Neutralizing Antibodies in CMV Infection: Implications for New Therapeutic Approaches. Trends in Microbiology 28:11, pages 900-912.
Crossref
Crossref
Alexandre Jentzer, Pauline Veyrard, Xavier Roblin, Pierre Saint-Sardos, Nicolas Rochereau, Stéphane Paul, Thomas Bourlet, Bruno Pozzetto & Sylvie Pillet. (2020) Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC). Microorganisms 8:7, pages 1078.
Crossref
Crossref
Sebastian J. Theobald, Christoph Kreer, Sahamoddin Khailaie, Agnes Bonifacius, Britta Eiz-Vesper, Constanca Figueiredo, Michael Mach, Marija Backovic, Matthias Ballmaier, Johannes Koenig, Henning Olbrich, Andreas Schneider, Valery Volk, Simon Danisch, Lutz Gieselmann, Meryem Seda Ercanoglu, Martin Messerle, Constantin von Kaisenberg, Torsten Witte, Frank Klawonn, Michael Meyer-Hermann, Florian Klein & Renata Stripecke. (2020) Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV. PLOS Pathogens 16:7, pages e1008560.
Crossref
Crossref
J. Reina. (2020) Current status of vaccines against congenital cytomegalovirus infection: The paradox of previous immunity. Vacunas (English Edition) 21:2, pages 111-120.
Crossref
Crossref
J. Reina. (2020) Estado actual de las vacunas frente a la infección congénita por citomegalovirus: la paradoja de la inmunidad previa. Vacunas 21:2, pages 111-120.
Crossref
Crossref
Dora Y. Ho, Kyle Enriquez & Ashrit Multani. (2020) Herpesvirus Infections Potentiated by Biologics. Infectious Disease Clinics of North America 34:2, pages 311-339.
Crossref
Crossref
Giuseppe Gerna & Daniele Lilleri. (2020) Human Cytomegalovirus Congenital (cCMV) Infection Following Primary and Nonprimary Maternal Infection: Perspectives of Prevention through Vaccine Development. Vaccines 8:2, pages 194.
Crossref
Crossref
Xinle Cui, Zhouhong Cao, Shuishu Wang, Stuart P. Adler, Michael A. McVoy & Clifford M. Snapper. (2020) Immunization with Human Cytomegalovirus Core Fusion Machinery and Accessory Envelope Proteins Elicit Strong Synergistic Neutralizing Activities. Vaccines 8:2, pages 179.
Crossref
Crossref
Morgan Hakki. (2020) Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy. Current Hematologic Malignancy Reports 15:2, pages 90-102.
Crossref
Crossref
Stanley A Plotkin, Dai Wang, Abdel Oualim, Don J Diamond, Camille N Kotton, Sally Mossman, Andrea Carfi, David Anderson & Philip R Dormitzer. (2020) The Status of Vaccine Development Against the Human Cytomegalovirus. The Journal of Infectious Diseases 221:Supplement_1, pages S113-S122.
Crossref
Crossref
Ibrahim AldossCorinna La RosaLindsey R. BadenJeffrey LongmateElla J. Ariza-HerediaWasima N. RidaChetan Raj LingarajuQiao ZhouJoy MartinezTeodora KaltchevaAndy DagisNicola HardwickNicolas C. IssaLen FarolAuayporn NademaneeMonzr M. Al MalkiStephen FormanRyotaro NakamuraDon J. Diamond. (2020) Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients. Annals of Internal Medicine 172:5, pages 306.
Crossref
Crossref
Peter A. Barry, Jesse D. Deere, Yujuan Yue, William W.L. Chang, Kimberli A. Schmidt, Felix Wussow, Flavia Chiuppesi, Don J. Diamond, Ellen E. Sparger, Mark R. Walter & Dennis J. Hartigan-O’Connor. (2020) Cytomegalovirus-vectored vaccines for HIV and other pathogens. AIDS 34:3, pages 335-349.
Crossref
Crossref
Johannes Koenig, Sebastian J. Theobald & Renata Stripecke. (2020) Modeling Human Cytomegalovirus in Humanized Mice for Vaccine Testing. Vaccines 8:1, pages 89.
Crossref
Crossref
Catherine S. Adamson & Michael M. Nevels. (2020) Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function. Viruses 12:1, pages 110.
Crossref
Crossref
Jose F. Camargo. 2020. Emerging Transplant Infections. Emerging Transplant Infections
1
44
.
Heidi Contreras, Felix Wussow, Claudia Fernández-Alarcón, Craig Bierle, Jenny Nguyen, Don J. Diamond & Mark R. Schleiss. (2019) MVA-Vectored Pentameric Complex (PC) and gB Vaccines Improve Pregnancy Outcome after Guinea Pig CMV Challenge, but Only gB Vaccine Reduces Vertical Transmission. Vaccines 7:4, pages 182.
Crossref
Crossref
Anat Stern & Genovefa A. Papanicolaou. (2019) CMV Prevention and Treatment in Transplantation: What’s New in 2019. Current Infectious Disease Reports 21:11.
Crossref
Crossref
Gogesch, Penner, Krauter, Büscher, Grode, Aydin & Plachter. (2019) Production Strategies for Pentamer-Positive Subviral Dense Bodies as a Safe Human Cytomegalovirus Vaccine. Vaccines 7:3, pages 104.
Crossref
Crossref
Xinle Cui, Zhouhong Cao, Shuishu Wang, Michael Flora, Stuart P. Adler, Michael A. McVoy & Clifford M. Snapper. (2019) Immunization of Rabbits with Recombinant Human Cytomegalovirus Trimeric versus Monomeric gH/gL Protein Elicits Markedly Higher Titers of Antibody and Neutralization Activity. International Journal of Molecular Sciences 20:13, pages 3158.
Crossref
Crossref
Mohammad Amin Behzadi, Kathryn R. Stein, Maria Carolina Bermúdez-González, Viviana Simon, Raffael Nachbagauer & Domenico Tortorella. (2019) An Influenza Virus Hemagglutinin-Based Vaccine Platform Enables the Generation of Epitope Specific Human Cytomegalovirus Antibodies. Vaccines 7:2, pages 51.
Crossref
Crossref